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ABSTRACT 
Despite advancement in global efforts to prevent mother-to-child transmission of HIV (PMTCT), 
more work needs to be done to protect children from HIV transmission particularly in eastern and 
southern Africa. The integration of PMTCT into routine antenatal care (ANC) services is one cost-
effective intervention for averting mother-to-child transmission (MTCT) of HIV. However, 
adherence to PMTCT services in ANC and throughout the breastfeeding period, when the infant is 
at risk of MTCT, is limited due to stigma, lack of knowledge and weak health systems in countries 
like Tanzania. 
 
The main aim of the thesis was to assess patient and provider satisfaction in PMTCT clinics, the 
potential for task-shifting and cost-effectiveness aspects of uptake of and adherence to the PMTCT 
programme in Dar es Salaam, Tanzania. 
 
Four studies were conducted based on data collected in Dar es Salaam in 2014 and 2016. In Paper I, 
we conducted a cross-sectional survey using Likert scale questions administered face-to-face to 595 
pregnant women living with HIV and attending ANC services. In Paper II, we used a self-
administered survey to 213 PMTCT providers. In Paper III, we used direct-time motion observations 
to assess time spent on each PMTCT task, and in Paper IV, we conducted a cost-effectiveness analysis 
from a providers perspective using health outcomes which were based on a secondary data analysis of 
de-identified health system data including a cohort of 2309 women newly diagnosed with HIV who 
delivered a baby between August 2014 and May 2016 in Dar Es Salaam. Descriptive statistics were 
used to summarize data in all four papers and logistic regression models were used to identify 
predictors of satisfaction/dissatisfaction (Papers I and II). 
 
Only 8% of patients were dissatisfied with PMTCT services, in particular with poor provider 
communication skills (OR 4.9, 95% CI 1.8 ± 1 3.4), low capacity to understand client concerns (OR 
5.7, 95% CI 2.3 ± 14.0) or if the hospital visits took over 2 hours (OR 2.3, 95% CI 1.1 ± 4.7) (Paper 
I).  
 
More than half of health care providers were dissatisfied with their current job and one third had 
turnover intentions. Dissatisfaction with the job was influenced by: low salaries (OR 5.6, 95%CI 
1.2-26.8), unreasonably long working hours (OR 3.2, 95% CI 1.3-7.6), unclear job descriptions (OR 
4.3, 95% CI 1.2-14.7) and poor safety measures (OR 4.0, 95% CI 1.5-10.6). Turnover intention was 
influenced by: poor job stability (OR 3.7, 95% CI 1.3-10.5), lack of recognition from one’s superior 
(OR 3.6, 95% CI 1.7-7.6) and inadequate feedback (OR 2.7, 95% CI 1.3-5.8) (Paper II). 
Nurses spent more time on the first antenatal and postnatal clinic visit (54 minutes, 95% CI 42–65 
and 29 minutes, 95% CI 26-32) than follow-up visits (15 minutes 95% CI 14-17) and 13 minutes, 95% 
CI 11-16).  A large proportion of this time (84%-100%) could be task-shifted to community health 
care workers. If these tasks were shifted to lower cadres, the average cost-saving per patient visit 
ranges from US$ 0.4 to 1.3 (Paper III).   
 
Most (91.3%) pregnant women living with HIV do not attend ANC in the first trimester, and more 
than half make fewer than 4 visits during the entire pregnancy. The overall MTCT rate was 2.8% 
(95% CI 2.2%-3.6%) at 12 weeks of life. More visits protected against HIV transmission: The MTCT 
rate was 4.8% (95% CI 3.6%-6.4%) for women with fewer than 4 visits and only 1% (95% CI 0.5%-
1.7%) for women who made at least 4 visits. The incremental cost-effectiveness ratio was US$ 336.37 
per MTCT averted when at least 4 visits were made, which is less than one year’s cost of HIV 
treatment for an HIV-positive infant initiating ART (Paper IV).  
 
In conclusion, patient satisfaction was influenced by good patient-provider interaction but providers 
themselves were not satisfied with their job for various reasons including high workload. Thus, 
interventions such as task-shifting can potentially improve job satisfaction, quality of care and 
retention in care and contribute to the elimination of MTCT in Tanzania and other resource limited 
countries. Furthermore, early uptake of and retention in ANC/PMTCT care can protect children from 
being born with HIV and also reduce future treatment costs for Tanzania. 
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1  GENERAL BACKGROUND 
1.1 HIV/AIDS 
Acquired Human Immunodeficiency Syndrome (AIDS) was recognized as a new disease in 
1980. The disease was present among previously healthy homosexual young men who 
presented with unusual infections such as Pneumocystis carinii (jiroveci) pneumonia, 
extensive mucosal candidiasis, and multiple viral infections (1). In early 1983, the human 
immunodeficiency virus (HIV) was isolated and in 1984 HIV was identified to be the 
causative organism for AIDS (2).  HIV causes gradual depletion of cluster of differentiation 
4 (CD4) positive T-cells, leading to progressive weakening of the immune system, 
increasing the susceptibility to opportunistic infections (3). The virus exists in two types; 
HIV-1 and HIV-2, but HIV-1 causes most of HIV infections worldwide (4).  Infection with 
either type can lead to the development of AIDS, but HIV-1 is more infectious and HIV-1 
infection progresses faster than HIV-2 (5).  
HIV infection is detected by the presence of HIV-specific antibodies in serum or plasma 
(for adults and children above 18 months of age) or the presence of the virus by nucleic 
acid detection using polymerase chain reaction (PCR) or p24 antigen testing. The main 
transmission mode of HIV is through sexual contact (80%). Mother-to-child transmission 
(MTCT) accounts for 10% of new HIV infections, while the remaining new infections are 
due to blood-borne exposure such as unsafe blood transfusion, sharing contaminated 
needles and other sharps (6). The proportions differ a lot between regions and population 
groups. Thus combinations of prevention strategies addressing these modes of transmission 
are recommended (7-9). Such strategies should at least involve providing education to 
reduce unsafe sex, syringe and needle exchange, screening of blood (10) and the cascade of 
strategies recommended for  prevention of mother-to-child HIV transmission (PMTCT) (9).  
  
1.2 EPIDEMIOLOGY OF HIV INFECTION 
1.2.1 Global situation 
Globally in 2016, there were 36.7 [30.8-42.9] million people living with HIV, including 1.8 
[1.6-2.1] million people who became newly infected.  About 1 [0.83-1.2] million people died 
from AIDS-related illnesses in the same year (11). This translated into a 32% and 16% global 
reduction in AIDS-related deaths and new HIV infections respectively between 2010 and 
2016. The epidemic is worse in eastern and southern Africa, home to over half of all people 
living with HIV in the world, with 59% of them being women (11) . 
To combat the HIV epidemic, in 2014 the Joint United Nations Programme on HIV/AIDS 
(UNAIDS) launched a fast-track approach for ending the global AIDS epidemic by 2030 
(12). The approach involves a set of targets known as 90-90-90, to be achieved by 2020. 
These targets require that 90% of people living with HIV should know their HIV status; 90% 
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of those who know their HIV-positive status should receive treatment; and 90% of people on 
treatment should have suppressed viral load (12). Substantial progress has already been made 
and in 2016 more than two thirds of all people living with HIV in the world knew their HIV 
status, of whom 77% were accessing antiretroviral therapy (ART) and 82% of people on 
treatment had undetectable viral load (13). World Health Organization (WHO) defines viral 
load suppression in low and middle-income countries as a viral load of < 1000 RNA copies 
per ml (14).  
The progress towards ending HIV epidemic in eastern and southern Africa was significant in 
2016.  In this region, about 76% of people living with HIV knew their status, of whom 79% 
were receiving ART, and 83% of those on ART had achieved viral suppression (13). 
However, these are estimates for only those who know their HIV status. Out of all people 
living with HIV, this translates as only 60% being on ART, and only half of them having 
achieved undetectable viral load (13). 
1.2.2 HIV and AIDS situation in Tanzania 
The total population of Tanzania was estimated at 53 million people in 2015(15). Nearly half 
of the population (45%) consists of young people aged less than 15 years (16). The 
population was projected to be 52 million in 2017 (15). Tanzania has an average real GDP 
growth rate of 7.8 %, and is the third country after Ghana (9%) and Ivory Coast (7.9%), 
showing the fastest growing economy in Africa (17).  Nevertheless, Tanzania remains a low-
income country, with 28% of the population living below the poverty line of less than 2 US 
dollars per day (15).  In addition, a Gross Domestic Product (GDP) per capita of 979 US 
dollars in 2016 is less than that of its neighbouring countries such as Kenya (1143 US$) and 
Zambia (1622 US$) (18). Despite prevailing poverty, the Government of Tanzania has a 
strong commitment to improving the health of the population and the country has made 
significant progress in many key health indicators. According to the Tanzania population and 
housing census conducted every ten years, life expectancy increased from 51 to 61 years 
between 2002 and 2012 (16). Furthermore, infant mortality declined from 95 to 46 deaths per 
1000 live births and under-five mortality declined from 153 to 67 per 1000 live births (16). In 
the fight against the HIV epidemic, the Government of Tanzania receives support from 
foreign donors who contribute about 97.5% of the treatment costs. The major donor is the 
President’s Emergency Plan for AIDS Relief (PEPFAR), which finances about 80 % of HIV 
activities in the country (19). To reduce donor dependency, an AIDS trust fund has been 
established with the aim of financing nearly one third of the national response by 2018(19) 
The first three cases of AIDS were diagnosed in 1983 in the Kagera region, and by 1986 all 
regions of Tanzania had reported AIDS cases (20). The HIV epidemic in the country is 
heterogeneous with geographical and population variability. In 2012, HIV prevalence 
ranged from 1% in Pemba, 6.9% in Dar es Salaam to a high of 14.8% in Njombe (21). The 
epidemic is mostly attributable to heterosexual transmission (80%), followed by MTCT 
(18%) and blood-borne infections, which account for 1.8% of all HIV infections (21).  
Scaling-up access to ART has minimized the impact of the epidemic, such that, between 
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2004 (when access to ART was limited) to 2016 (when 63% of adults had access to ART), 
prevalence dropped from 7.1 percent to 4.7 percent (11).  Furthermore, between 2010 and 
2016, a 53% reduction in AIDS-related deaths and 18% reduction in new HIV infections 
were reported (11). Despite the decline, in 2016 there were still 1.4 [1.2-1.6] million people 
living with HIV, including 55000 [42 000–67 000] who were newly infected in Tanzania 
(11). The current progress shows that, by 2016 only 70% of 1.4 million people living with 
HIV knew their status, and of these 88% had initiated ART. However this represented only 
63% of all people living with HIV who were on treatment and the records for those who 
had achieved viral suppression were not available (13). Thus, additional efforts are required 
to achieve the 90-90-90 targets and to end the HIV epidemic in Tanzania by 2030.   
 
Table 1. Key indicators for the United Republic of Tanzania 
Indicator Number /Percent 
Total population (2015)  534 704 000 
Population proportion (%) under 15 years  45.2 
Total fertility rate (number of children per woman) 5.2 
GDP per Capita (2016) USD 979 
Life expectancy in years  (average; Male: Female)  61.8 (M; 59.8:F; 63.8) 
Literacy rate (%) among adults 15 years and over  73 
Median age at first marriage for women age 25-49 (years) 19.2   
Women age 15-19 who are mothers or currently pregnant (%) 27  
Total demand for family planning (%)  61  
Births delivered in a health care facility (%) 63  
Children (12-23 months) who received all basic vaccinations (%) 75  
Children under five (%) who are stunted (moderate or severe)  34 
Infants exclusively breastfed in the 1st 6months of life (%) 59.2 
Neonatal mortality (per 1 000 live births) 25  
Infant mortality  (per 1 000 live births)  43   
Under 5 mortality (per 1 000 live births)  67   
Maternal mortality ratio (per 100 000 live births (2015) 398 
Physician density (per 1 000 population) 0.03 
Nursing and midwifery personnel density (per 1 000 population) 0.45 
Total expenditure in health as % GDP (2014) 5.6 
Private expenditure in health as % of total expenditure on health 53.6 
Government expenditure on health as % of total expenditure  12 
 
Adopted from key indicators. Tanzania national bureau of statistics. Statistics for development: Retrieved 
from http://www.nbs.go.tz Copyright National Bureau of Statistics 2017. 
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1.3 PREVENTION OF HIV 
While a cure or an effective HIV vaccine is not yet available, a combination of behavioural, 
structural and biomedical interventions targeting the main methods of HIV transmission 
remains an important aspect of HIV prevention (7-9).   
Behavioural interventions focus on providing context-specific health education to the 
communities to promote low-risk behaviours known to be effective in decreasing new HIV 
infections (10, 22, 23). These interventions include promoting safe sex behaviour, 
increasing condom use, decreasing the number of sexual partners, delaying the onset of 
sexual intercourse, improving treatment adherence among people living with HIV, sexual 
education of youth and improving communication with partners regarding safer sexual 
practices (8, 24). 
Structural interventions focus on modifying the structural context where health is produced 
and reproduced to influence the availability, acceptability and accessibility of the materials 
or environments needed to maintain safe behaviours (25). This involves complex 
interventions to change the social, economic, political and environmental factors that have 
an impact on resilience and vulnerability to HIV (26). Harm reduction, such as needle and 
syringe exchange, is among the structural interventions shown to be effective in reducing 
the spread of HIV among people who inject drugs (27, 28).  
Biomedical interventions such as male circumcision (29), barrier methods such as condom 
(30), antimicrobial products (31), HIV treatment as prevention also referred to as TasP (32), 
pre-exposure prophylaxis (33) as well as PMTCT (34), represent significant breakthroughs 
in the field of HIV prevention. However, since none of these interventions is 100% 
effective, a combination of them is essential for improved outcomes. The success of 
preventive actions is dependent not only on behavioural factors affecting the uptake of and 
adherence to various protective interventions but is also affected by health system 
structures and access to effective biomedical interventions (35).    
 
1.4 TREATMENT OF HIV 
There is no cure for HIV, but ART can control HIV, revert AIDS and greatly improve 
survival and quality of life for people living with HIV (36, 37). Thus, when effectively taken, 
ART can lead to adequate and sustainable viral load suppression, improve CD4 T-cell counts 
and halt the clinical progression of the HIV infection (38).  
ART are grouped into classes according to how they act, and the selection of regimen 
includes three medicines (triple therapy) from at least two different HIV drug classes. These 
include nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase 
inhibitors, protease inhibitors, fusion inhibitors, entry inhibitors and integrase strand transfer 
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inhibitors (39). WHO makes generic recommendations that are adapted and implemented in 
low-and middle-income countries.   
WHO recommends rapid ART initiation (within 7 days of diagnosis) to all people living with 
HIV after a confirmed diagnosis and following the clinical assessment, an approach referred 
to as “test and treat” (14).  For adults (including pregnant women) and children older than 10 
years, WHO recommends an ART drug combination of tenofovir (TDF), and either 
lamivudine (3TC) or emtricitabine (FTC) and efavirenz (EFV) as the first-line treatment 
regimen for adults (14).The recommended first-line ART  regimen for children between 3 
and 10 years is a combination of Abacavir (ABC) and 3TC and EFV whereas for children 
younger than 3 years, a combination of ABC or Azidothymidine, also known as Zidovudine 
(AZT)+ 3TC+ Lopinavir/ritonavir (LPV/r), is recommended (14).   
 
1.5 MOTHER-TO-CHILD TRANSMISSION OF HIV 
1.5.1 Key MTCT concepts     
MTCT of HIV refers to the transmission of HIV from a pregnant woman living with HIV to 
her child during pregnancy, labour, delivery or breastfeeding. The risk of transmission is 
mostly influenced by the high maternal plasma viral load and deterioration of maternal 
disease stage. This is made worse by vaginal delivery, prolonged rupture of membranes, 
prematurity and breastfeeding, factors that expose the infant to maternal blood, vaginal 
fluids and breast milk contaminated with the virus (40). MTCT accounts for 90% of HIV 
infections in children, making it the main route of transmission among the children below 
15 years (9). In the absence of any intervention, about 15-45 % of HIV-infected mothers 
will transmit infection to their unborn children, 5-10% during pregnancy, 10-15% during 
labour and delivery and 5-20% during breastfeeding (9). However, if these women have 
access to antiretroviral therapy, the risk of transmission drops to less than 5% (41).  
Women of childbearing age still account for nearly half of the adults living with HIV in the 
world, with only 60% of them accessing ART (11). New infections among children 
contribute about 11% of all incident HIV infections and 13% of total HIV-related deaths 
globally (11). Infants living with HIV have higher rates of disease progression to AIDS and 
death than older children and adults, even with high CD4 lymphocyte counts (42). The 
mortality is so high that without treatment almost one third (35.2%) will die before their first 
birthday and slightly over half (52.5%) will die before they reach two years of age (43). Since 
PMTCT is the most effective way to avoid HIV infection and prevent deaths in children; it 
is considered an essential part of maternal, new born, and child health care. Furthermore, by 
eliminating MTCT (EMTCT), defined as a reduction in final MTCT rate to ≤5% among 
breastfeeding populations, and ≤ 2% among non-breastfeeding populations (44), the dream 
of an HIV-free generation will be achieved. 
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1.5.2 Prevention of mother-to-child transmission of HIV 
WHO recommends a strategy for comprehensive PMTCT globally, with four prongs which 
are to: (i) prevent HIV infection among women of childbearing age, (ii) prevent unintended 
pregnancies in women living with HIV, (iii) prevent HIV transmission from women to their 
infants and (iv) provide care, treatment and support for mothers living with HIV, their infants 
and families. Thus PMTCT promotes the health-related sustainable development goal (SDG), 
that requires countries to ensure healthy lives and promote well-being for all at all ages, and 
in target 3.3 to end the AIDS epidemic by 2030 (45). These approaches are challenged by 
several factors including weak health systems that limit access to HIV testing, prevention and 
treatment in many settings (46, 47). Furthermore, about 38% of pregnancies that occur each 
year globally are unplanned (48) and the unmet need for contraception remains high 
especially in sub-Saharan Africa (49). However, the opportunity for prevention exists as the 
majority (85%) of pregnant women globally attend antenatal care (ANC) clinics at least 
once during their pregnancy (50). This provides opportunity to initiate ART for preventing 
MTCT and promoting the survival of infants, and their families as well as decreasing 
transmission in communities.     
1.5.3 The global history of PMTCT   
The history of PMTCT can be traced back to 1983, when the paediatric HIV infections were 
linked to the MTCT, and the only preventive strategy was to provide testing for HIV and 
advise women living with HIV to avoid pregnancy (51). Since then PMTCT has undergone 
substantial advancement based on scientific evidence from research (Table 2). A huge 
breakthrough was marked in 1994, when AZT was found to reduce MTCT by approximately 
two thirds (52) and became the first available antiretroviral agent for PMTCT. However, the 
cost and complexities of using AZT made it less feasible for resource-limited settings, where 
safe and acceptable breastfeeding alternatives are limited (53). In the early 2000s, a second 
major discovery made Nevirapine prophylaxis (single dose at the onset of labour and infant 
single dose within 72 hours of life) a feasible option for both breastfeeding (54, 55) and non-
breastfeeding populations (56). Based on the available evidence (53, 57), WHO’s 
recommendation was modified in 2004 to accommodate extended use of AZT from 28 weeks 
of pregnancy to prevent MTCT and lifelong ART for women with a CD4 cell count less 
than 200 per µL (57).  In 2006, in addition to the use of AZT during pregnancy, WHO added 
seven days of AZT to the mother and to the infant (58). This became possible following the 
availability of ART in many low-income countries supported through PEPFAR funding. 
However, this type of early MTCT prevention was limited to a few weeks after delivery and 
the long-term efficacy of PMTCT was reduced by subsequent MTCT during breastfeeding 
(59, 60). To prevent emerging drug resistance against antiretroviral drugs, WHO updated its 
guidelines again in 2010 in order to discourage the use of single drug regimens aiming to 
prevent resistance. Furthermore, among other things, the 2010 guidelines encouraged 
universal access and longer duration of triple ART during pregnancy (from 14 weeks of 
gestation) and during the breastfeeding period, which was extended to at least 12 months 
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(61). The two proposed options were option A (maternal AZT during pregnancy, coupled 
with infant Nevirapine during breastfeeding) and option B (maternal ART during pregnancy 
and breastfeeding) (61) 
Subsequently, more evidence suggested it was possible to achieve EMTCT with the use of 
both perinatal and postnatal ART (62, 63). UNAIDS and PEPFAR proposed new ambitious 
goals to reduce the number of new HIV infections occurring through MTCT by 90% and 
halve HIV-related maternal deaths (64). Priority was given to the 22 countries that accounted 
for 90% of pregnant women living with HIV worldwide including Tanzania (65).  
The global progress in reducing MTCT has been dramatic and WHO has already validated 
that some countries in Europe and Latin America have eliminated the MTCT of HIV and 
syphilis (66-68), a proof that MTCT can be eliminated in real-life settings. The success in 
these countries was driven in part by their effort to ensure that women had early access to 
prenatal care, HIV and syphilis testing together with their partners, treatment for women who 
tested positive, safe infant feeding and treatment for their infants if they became infected (66-
68).  However, progress is slow in the Global Plan priority countries where health system 
challenges still limit the real-life effectiveness of PMTCT interventions (69). More than 1.4 
million pregnant women globally were living with HIV in 2016 but only 77% accessed ART, 
and about 160 000 new infections occurred among children that year (69). Thus, the 
availability of guidelines and effective PMTCT medicines alone will not be enough to 
achieve EMTCT. Thus, a strong commitment is required to scale up the PMTCT service 
uptake, retention as well as efforts to support adherence to ART throughout pregnancy and 
breastfeeding (70), and for life if we are to fulfil the aspirations and benefits associated with 
PMTCT Option B+ . 
Barriers towards reaching the EMTCT target include the continued lack of functioning health 
systems that can ensure equitable and universal access to antenatal and post-natal care. 
However, the strengthening of health systems in Tanzania and elsewhere in sub-Saharan 
Africa is an on-going albeit too slow process, limiting the real-life effectiveness of PMTCT 
interventions and hampering progress towards the EMTCT target across the Global Plan 
priority countries (69). Another critical component at health system level is the integration of 
maternal and child health care with HIV and PMTCT care, an important step towards 
improving the uptake of health services and better health outcomes (71). The process of 
integration of PMTCT into standard routine ANC is moving faster than the strengthening of 
other components of the health systems in countries like Tanzania. 
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Table 2.   Milestones of WHO PMTCT guidelines development  
Year of 
recommendation 
PMTCT recommendation (prophylaxis) Recommendation 
for life long ART 
 
 
2001 
AZT during 4 weeks of pregnancy + AZT+ 
3TC during labour, or single dose Nevirapine 
(NVP) at the onset of labour 
NONE 
 
 
2004 
AZT starting at 28 weeks of pregnancy + 
single dose NVP at the onset of labour 
CD4<200 cells per 
µL 
 
 
         2006 
AZT starting at 28 weeks of pregnancy + 
single dose NVP at the onset of labour 
+AZT/3TC for 7days post delivery 
 
CD4<200 cells per 
µL 
 
 
 
 
        2010 
Option A 
AZT starting at 14wks of pregnancy until 7 
days post-delivery + infant NVP from birth 
till end of breastfeeding 
Option B 
Combination ART starting at 14 weeks of 
pregnancy until end of breastfeeding and 
infant NVP for the first 6 weeks of life 
 
CD4<350 cells per 
µL 
 
 
        2013 
Option B or B+   
Lifelong ART for all HIV+ pregnant women 
starting as soon as possible after diagnosis 
CD4<500 cells/ mm3 
 
 
        2015 
Test and treat all people living with HIV 
(including non-pregnant women) 
ALL people living 
with HIV 
Adapted from publications on mother-to-child transmission of HIV. Retrieved from http://www.who. int/hiv/ 
pub/ mtct/en/ Copyright World Health Organization 2017.  
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1.5.4 Progress in PMTCT towards EMTCT of HIV in Tanzania 
Tanzania is among the 22 Global Plan priority countries targeted for EMTCT of HIV 
because it is among the countries that accounts for 90% of pregnant women living with 
HIV in the world and a high number (86 000) of annual deliveries also occur among these 
women (69). Tanzania began offering PMTCT services in 2000, starting with five tertiary 
care hospitals located in the Dar es Salaam, Kilimanjaro, Mwanza, Mbeya and Kagera 
regions (72). This started as a pilot programme initiated by the Tanzanian Ministry of Health 
in collaboration with the United Nations Children's Fund (UNICEF) to assess the feasibility 
of integrating PMTCT within routine ANC (72). Subsequently, integrated ANC/PMTCT 
services were scaled up in all the regions in the country. The national PMTCT guidelines 
were adapted from the generic WHO guidelines and the subsequent revisions are based on the 
WHO updates (Table 2). Currently, Tanzania is implementing Option B+ (73) as well as a 
“test and treat” approach (14).  
Although Tanzania falls short of the EMTCT goal, by 2016 it had made significant progress 
towards EMTCT as it had achieved a 69% MTCT reduction since 2009 when the Global 
Plan target, aiming at 90% reduction by 2015 was set (69). Furthermore, the MTCT rate at 
the end of breastfeeding has gone down to 8% but not yet to the Global Plan target level of 
less than 5% (69). The progress so far can be attributed to the use of effective PMTCT 
regimens including Option B+ and also increased access to ART by pregnant women living 
with HIV (11). In addition, so-called integrated ANC/PMTCT services are provided in 93% 
of all health care facilities in the country and about 98% of pregnant women attend ANC at 
least once during pregnancy (74). Pregnant women in Tanzania also have adequate 
knowledge about PMTCT (75) and almost all pregnant women who receive HIV testing and 
counselling consent to testing (75, 76). Since these women are already accessing ANC, the 
health system should support them to enter and successfully migrate through the PMTCT 
cascade (Figure 1) until the final HIV status of their infants is known (77).  
WHO recommends that infants exposed to HIV be tested at the first postnatal visit usually 
when they reach four to six weeks of age or at the earliest opportunity thereafter, and that 
those who are infected should start treatment immediately (77). However about half of HIV-
infected infants still do not receive an HIV test as recommended (69). Thus it is crucially 
important to strengthen health systems to ensure the uptake and continuity of migration 
through the PMTCT cascade in order to move towards EMTCT (78).   
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Figure 1. The PMTCT cascade. Adapted from the Tanzania guidelines for comprehensive care services for 
prevention of mother-to-child transmission of HIV and keeping mothers alive, by the United Republic of 
Tanzania 2013. by ministry of health and social welfare 
 
1.6 IMPLEMENTING PMTCT WITHIN THE EXISTING HEALTH SYSTEMS 
 
1.6.1 Framework of efficient health system building blocks   
The service delivery and utilization of PMTCT services can be largely affected by health 
system factors, and made worse by co-existing social and cultural factors (46, 79). WHO 
recognizes health service delivery as a pillar of a health system and the main output is to 
ensure the delivery of quality services that are accessible, equitable, safe, and responsive to 
the needs of the consumers (80) Thus to deliver such services, WHO recommends health 
system strengthening in all six of its building blocks (Figure 2), including (i) Service 
delivery, (ii) Health workforce, (iii) Health information system, (iv) Access to essential 
medicines, (v) Financing and (vi) Leadership/Governance (80). 
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Figure 2. The WHO Health systems framework. Reprinted from Everybody's business: strengthening 
health systems to improve health outcomes: WHO’s framework for action (p.3), by the WHO Document 
Production Services, Geneva, Switzerland Copyright World Health Organization 2007.  
 
1.6.2 Tanzanian health system 
1.6.2.1 Health system organization 
The health system in Tanzania is organized in a hierarchical system that mimics the 
government structures of leadership. The different levels of services are organized in a 
pyramid system, on top of which there are specialized hospitals providing tertiary level 
care, while at the bottom are the primary health care facilities (dispensaries, health centres 
and district hospitals) where most ANC/PMTCT services are provided (Figure 3). At the 
community level, there is a village health unit where a community health worker (CHW) 
provides basic preventive health services within the community (81).     
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Figure 3. Organizational structure of health care delivery system in Tanzania and the proportion of  
available health care facilities. Adapted from The United Republic of Tanzania Human resource for health 
country profile 2013 by ministry of health and social welfare retrieved from http://www. tzdpg. or.tz / 
fileadmin/documents/dpg_ internal/dpg_working_groups _clusters/cluster_2/health/ Key_Sector_Documents/ 
HRH_Documents/Final_Country_Profile_2013.pdf   
 
1.6.2.2 Health service delivery  
Tanzania has about 6549 dispensaries, 718 health centres and 252 hospitals (public and 
private) throughout the country. It is estimated that 1.5 health care facilities serve at least 
10 000 people (82) over 90% of whom live within 5 km of a health care facility (83). Some 
inequalities in the distribution of health care facilities among rural and urban areas do exist 
and this limits patient access to quality health care especially in rural areas (84). According to 
a service availability survey conducted between 2005 and 2006 in most of the districts of 
Tanzania, the ratio of health care facilities per 10 000 people between public and private was 
1:2, with a higher concentration of private facilities in urban areas (82). Poor utilization of 
services is a challenge, as only one in four women initiate their first ANC visit during the first 
trimester of pregnancy and nearly half the pregnant women do not comply with the WHO 
recommended minimum of 4 focused ANC visits (74). Inconsistent visits (85), and poor 
adherence to ART during pregnancy and breastfeeding have been associated with poor 
MTCT outcomes (85, 86). Thus to eliminate MTCT and keep mothers alive, more 
commitment is required to ensure that pregnant women living with HIV have early access to 
ART and enough support to migrate successfully into the PMTCT cascade (77).  
Specialized/consultant hospitals 
(0.1%) 
Regional hospital (0.4%)                       
1 Hospital  /1 Million population 
District hospital (3.2%)                           
1 bed per 1 000 population   
Health centres (10.3%)                            
1 Health center, per 50 000 population 
Dispensaries (86%)                                  
1 Dispensary per 10 000 population 
Village Health Service                            
2 health workers /village 
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1.6.2.3 Health workforce    
There are 153 registered health-training institutions in Tanzania, more than half of which 
are owned by the government (87). These include 10 medical universities, which produce 
about 700 medical doctor graduates, and 70 training institutions, producing 2718 nurses, 
and midwife graduates per year (87). Despite the fact that the government employs nearly 
70% of the graduates, the health sector in the country still faces a critical shortage (56%) of 
trained health workers and the physician density of 0.4 per 10 000 people (87) is far below 
the ratio (23 per 10 000) recommended by WHO for offering effective basic health services 
(88). The shortage is most pronounced in primary health care facilities where most of the 
PMTCT services are offered (87, 89). The shortage is extended to the health professionals 
in the health training institutions, where the estimated deficit is nearly one third (87). 
Contributory factors include inadequate funds for training, and limited numbers of 
institutions and trainers. As a result, low numbers of health care providers are trained, 
limiting the pool of health care providers to be recruited and to be allocated to the health 
care facilities (87). These challenges are further exacerbated by poor retention of staff. In 
2013, out of all health care providers employed by the government, only 63% reported for 
work and of these 13% left for various reasons (87). Staff retention is even worse in rural 
areas where the working conditions are poor, for instance there is no comfortable staff 
housing available, the roads are poorly maintained and essential social services are limited 
(90).  
1.6.2.4 Health Information System 
Before 2013, the Ministry of Health in Tanzania was using a health management information 
system that required each health care facility to summarize data manually and send it to the 
district for compilation of district statistics. From the district level, data was then sent 
manually or electronically to the regional level and subsequently to the national level (87). 
This system was associated with challenges related to poor data completeness, consistency 
and linkage, especially linkage of mother-infant pairs in PMTCT. The system has now been 
replaced by the District health information Software 2, which includes an open-source health 
management data platform and is currently being implemented in 47 countries in the world 
(91). The software uses mobile phones to send data from the health care facility directly to a 
central database. As part of the upgrade, computers have been procured and installed in all 
districts and health care facilities in the country and data collection and reporting tools are in 
place at all health care facilities and district offices (87).    
1.6.2.5 Access to essential medicine and medical supplies  
Medicines and medical supplies in Tanzania are provided through the public non-for-profit 
system (56%), while the remaining proportion is through the private-for-profit sector (82).  
The medical store department (MSD) is responsible for ordering and distributing all the 
medical supplies used in public health care facilities (92). Private health care facilities 
procure medical supplies from MSD and also from other sources such as private 
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pharmacies. MSD’s procurement process can take about three months for purchases from 
local suppliers and six to nine months for international procurement (93).  
The major concern is stock-outs of medicines and other commodities, especially in rural 
public primary health care facilities (82).  Threats to the quality of PMTCT care, such as 
stock out of HIV test kits, ART and infection prevention supplies, have been reported in 
ANC/PMTCT facilities in Tanzania (94). Apart from limited funds with which to purchase 
adequate medical supplies, the weakness in supply chain management at health care facility 
level (poor forecasting) and central level (inadequate filling and delivering orders) is an 
additional challenge (95). To minimize the problem MSD has changed its procurement 
modality and from 2017 medicines and medical supplies are procured directly from 
manufacturers instead of suppliers (92). 
1.6.2.6 Health care financing 
Tanzania relies on a mix of financing sources such as taxation (26%), donor funding (40%), 
out-of-pocket payments (32%), and prepayment schemes (2%) to support its health care 
system (96). The domestic share contribution to the health budget in 2015/16 was estimated 
at 82% and health expenditure as a percentage of total government expenditure was 11.3 % 
(97). This is less than the recommendation in the Abuja Declaration that countries should 
spend 15% of the annual government budget on improvement of the health sector. The 
commitment was signed in April 2001 by African union countries, including Tanzania (98). 
Total expenditure on health as a proportion of GDP in 2014 was 5.6 %, which is less than 
in Uganda (7.2%) and in Rwanda (7.5%) (99). Given the insufficient contribution from the 
domestic funds, the national HIV programme including PMTCT care is largely donor-
dependent and the PEPFAR supports 98.8% of the costs for ART (19).   
1.6.2.7 Leadership/Governance 
The President’s Office Regional Administration runs the primary health care facilities 
through the local government authorities (which are responsible for implementation of 
health services) within the districts. District councils take full responsibility for executive 
tasks in health and social welfare. Regional Health Management Teams provide technical 
support to all public and private health service providers to improve the quality of the 
Council health services, without taking over operational responsibilities (93). The Ministry 
of Health, Community Development, Gender, Elderly and Children has regulatory power 
over all health care facilities. The Ministry is responsible for the formulation of health 
policy, goals and guidelines as well as guiding their implementation (93). All public and 
private health care facilities in the country are guided by the national health policy; in 
addition, the Private Practitioners Act regulates private practice. Despite this well-
established leadership system, the accountability, health information reporting, and 
feedback at primary health care level is limited by the inadequate capacity of leaders to 
perform their work (93). 
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1.6.3 Improving effectiveness in PMTCT implementation 
With the availability of the regimen with proven efficacy for PMTCT, efficient PMTCT 
service delivery that meets a minimum standard for quality care is essential for achieving 
EMTCT targets. WHO recommends Option B+ for PMTCT as it has proved to be effective 
in EMTCT and a cost-effective intervention. Apart from being effective in PMTCT, with 
benefits also extended to future pregnancies, the option is effective in preventing infections 
to partners and improving maternal health (77). Nevertheless, in the review of modelled 
cost-effectiveness studies, Option B/B+ was found to be more cost-effective than the 
previous options in the prevention of infections to the partner and infant and to have 
potential for reducing future treatment costs (100). However, the success and benefits of 
this intervention are dependent on effective implementation, which can be hampered by the 
health system factors (46).  
It is important to note that pregnant and breastfeeding women may not be utilizing PMTCT 
services efficiently also because of social or behavioural problems, such as HIV-related 
stigma, lack of partner support or negative attitudes toward health care providers (78). There 
is some evidence that social intervention to support these mothers, such as the involvement of 
male partners, peer mentors and CHWs, can improve the uptake of ART, retention in 
PMTCT services, and the uptake of early infant HIV testing (101). Similarly, behavioural 
intervention, such as the use of mobile phone-based reminders, has also shown some positive 
effect in these areas (101). While structural interventions, such as conditional cash transfer, 
training of midwives, integration of PMTCT services and enhanced referral, have some 
positive effect on the uptake of ART and infant HIV testing but not on retention in PMTCT 
care (101).   
The available results of the economic evaluation of such interventions show that involvement 
of male partner was cost-effective in increasing HIV-testing among pregnant women as well 
as averting MTCT (102). Furthermore, the integration of PMTCT services in routine maternal 
and child health services was cost-effective in increasing PMTCT uptake and averting MTCT 
(103).   
The question is how we motivate these pregnant women living with HIV to utilize the 
available services in order to receive these benefits, while remembering that these women 
present to the PMTCT health care facilities with various needs. These women expect high 
quality health services, physical comfort and emotional support (104), and if their 
expectations are not adequately met, they lose confidence in the health system (105). Patient 
satisfaction with the health services is an output of a well-functioning health system (80).  
Health care providers’ interpersonal quality care is a service delivery indicator with a strong 
influence on patient satisfaction (106). Thus, patient-provider interaction, characterized by 
good communication and patient-centred care, is necessary for a positive influence on 
patient satisfaction and retention in HIV care (104). Furthermore, patients are dissatisfied 
with health services provision in health care facilities where health care providers are 
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dissatisfied or burned out (107). While the providers are expected to deliver services that 
meet the clients’ needs, their own needs are sometimes not being met and, as a consequence, 
they can also become dissatisfied (108). For instance, their motivation may be limited by 
poor working conditions, low remuneration, work-related stress, and unclear description of 
roles and responsibilities as well as limited organizational and professional commitment 
(108).  
WHO recognizes task-shifting, also referred to as task-sharing, as the rational redistribution 
of tasks among the available health care providers. Thus, based on a major global shortage of 
health care workers, WHO recommends task-shifting as a part of the solution for achieving 
universal access to HIV/AIDS services (109). Task-shifting is defined by WHO as a 
process of delegation whereby tasks are moved, where appropriate, to less specialized 
health care providers (109). Task-shifting is not a new concept; it has also been practised in 
the form of moving some tasks with appropriate supervision, from highly qualified health 
care providers to less well-qualified health care providers (110, 111). When properly 
executed, the task-shifting model can result in a more efficient use of the available 
workforce without compromising the quality of care (112).  
As a response to the HIV epidemic, the task-shifting model has also used CHWs and lay 
counsellors to improve health systems efficiency for implementation and scale-up of 
various interventions in low-and middle-income countries (113). In March 2016, the 
government of Tanzania signed a task-sharing policy, which will allow trained CHWs to 
perform rapid HIV testing (19). A task-shifting model using CHW was found to reduce 
workload of the health care providers, improve quality of service delivery and also improve 
patient satisfaction with services (114). Hence, CHWs are key partners in service delivery, 
although they face challenges including a lack of recognition, low or no remuneration and 
little involvement in decision-making (115). Furthermore, based on their capacity to link 
community and health care facilities, CHWs can promote the uptake of voluntary HIV 
testing, PMTCT counselling, adherence counselling and home-based care support to people 
living with HIV (112). Previous studies have shown that, task-shifting can result in 
substantial cost-saving and clinician’s time saving without compromising the quality of 
care (116).  
Thus, in countries where there is a critical workforce shortage like Tanzania, increasing the 
number of health care providers rapidly to meet the demands of PMTCT care may not be 
feasible, due to the challenges related to training, recruitment, and allocation, exacerbated by 
poor retention, task-shifting can be used as a short term solution. However, WHO advises 
that long-term efforts to train, recruit and retain more qualified health care providers should 
not be replaced by the use of CHWs. In addition, the health system should ensure that CHWs 
receive appropriate training, formal recognition and remuneration (109). 
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2 THE RATIONALE FOR THIS THESIS 
MTCT continues to be a significant problem especially in sub-Saharan Africa and is denying 
children the opportunity of HIV-free survival. Tanzania is among the 22 countries with the 
highest number of pregnant women living with HIV, and as such is a targeted country for 
EMTCT.  The country has made significant progress in cutting down the number of new HIV 
cases among children but still, the MTCT rate is 8% and there are 10 000 new infections 
among Tanzanian children annually (11). This is a cause for concern because clinical trials 
conducted in the country have shown promising results regarding the feasibility of reducing 
MTCT to rates of less than 5%, which is the EMTCT target (117).   
With the introduction of PMTCT Option B+ (77), global and national policy on PMTCT 
aimed to go beyond the obvious focus of keeping infants free of HIV infection, by also 
focussing on the health of the mother in the long-term (44). Previous PMTCT strategies 
(61) mainly focused on preventing MTCT by using ART throughout the breastfeeding 
period. With the current strategies, all pregnant women living with HIV are supposed to be 
initiated on ART for life regardless of their CD4 cell count, to keep them alive (14, 77). 
The purpose is to facilitate the process for health care providers who previously had to 
choose between various PMTCT options, to make sure women stay on ART throughout the 
breastfeeding period. By keeping the woman on ART, any future children would 
automatically be protected against HIV transmission, and secondary transmission to sexual 
partners would also be strongly reduced (TasP) (77)  
For Tanzania to achieve the EMTCT, the identification of the implementation gaps that 
limit effective PMTCT is crucial. Unlike in clinical trials, resource-limited health systems 
with shortcomings in relation to governance, financing, human resources, medicines and 
technologies as well as health information systems will impact policy implementation and 
service delivery (80). In addition, user barriers (social, economic, cultural and knowledge 
gaps) are major challenges to the uptake of services and retention in care in real-life settings 
(46, 94, 118). When it comes to HIV care, the stigma attached to this infection and the real 
risk of discrimination and social exclusion that many women living with HIV face makes 
PMTCT uptake and retention particularly complicated, requiring insightful and 
contextually adapted solutions. 
This thesis focuses on three of the health system building blocks, including health service 
delivery, health workforce and financing, and studies the possible barriers to accessing 
PMTCT services in Dar es Salaam, Tanzania, when the country was switching to PMTCT 
Option B+. The first paper of this thesis (Paper I) examined whether patients were satisfied 
with the PMTCT services they received and which factors led to dissatisfaction, given that 
dissatisfied patients are thought to adhere more poorly to health services. The second paper 
(Paper II) examined the other side of the coin, i.e. the satisfaction of health care providers 
working with PMTCT, assuming that a dissatisfied health care provider is less likely to 
provide good services. The third paper (Paper III) identified PMTCT tasks that could be task-
shifted from trained health care providers (primarily nurses), who are in short demand, to 
 26 
lower-qualified staff cadres, such as CHWs, to alleviate some of the problems and improve 
efficiency. Finally, the last paper (Paper IV) looked at the effect of early enrolment and 
adherence to ANC/PMTCT care, including the minimum number of 4 ANC visits 
recommended by WHO in 2001, on possible future cost savings resulting from averting 
MTCT.  
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3  OBJECTIVES 
3.1 GENERAL OBJECTIVE 
To assess patient and provider satisfaction, potential for task-shifting and cost-effectiveness 
aspects of uptake and adherence to the PMTCT programme in terms of preventing MTCT of 
HIV in Dar es Salaam, Tanzania.  
3.2 SPECIFIC OBJECTIVES  
1. To assess patient satisfaction and factors related to dissatisfaction with PMTCT care in 
public health care facilities in Dar es Salaam, Tanzania (Paper I) 
2. To assess the level of job satisfaction and intention to leave the current job among health 
care providers in public health care facilities offering PMTCT/ANC services in Dar es 
Salaam, Tanzania (Paper II) 
3. To measure the average time nurses spend on delivering the different PMTCT tasks and to 
estimate potential savings in terms of cost and workload that could be achieved by shifting 
some tasks to lower cadre staff (community health workers) in health care facilities providing 
PMTCT services in Dar es Salaam, Tanzania. (Paper III) 
4. To evaluate the cost-effectiveness of adherence to the recommended minimum of 4 ANC 
visits on MTCT among pregnant women living with HIV under PMTCT Option B+ in Dar es 
Salaam, Tanzania. (Paper IV) 
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4  MATERIAL AND METHODS 
4.1 GENERAL SUMMARY OF MATERIAL AND METHODS 
Table 3: Summary of methods in the papers included in the thesis  
Papers Study 
design 
Data collection  
Study Population 
Main 
outcome  
Main analysis 
 I Quantitativ
e cross 
sectional 
survey 
Structured interviews 
600 pregnant and 
breastfeeding women living 
with HIV, receiving 
PMTCT care in public 
health care facilities in Dar 
es Salaam, between March 
and April 2014. 
Patient 
dissatisfaction 
with PMTCT 
services  
Descriptive 
statistics and 
multivariate 
logistic 
regression 
analysis 
     
 II Quantitativ
e cross 
sectional 
survey 
Structured interviews 
250 Health care providers 
providing PMTCT care in 
public health care facilities 
in Dar es Salaam between 
March and April 2014. 
Provider job 
satisfaction 
and turnover 
intention in 
PMTCT 
clinics  
Descriptive 
statistics and 
multivariate 
logistic 
regression 
analysis 
     
  III Time and 
motion 
study 
Direct observation and 
Mapping of task to potential 
skill abilities of CHW 
179 Patient-provider 
interactions in public health 
care facilities in Dar es 
Salaam observed between 
March and April 2014. 
Time spent in 
each PMTCT 
activity. Time 
and cost that 
could be saved 
by task-
shifting  
 
Descriptive 
statistics  
     
  IV Cost-
effectivenes
s analysis  
Micro-costing and 
secondary analysis of de-
identified, routinely 
collected health system data 
2436 women newly 
diagnosed to be living with 
HIV, who delivered 
between August 2014 and 
May 2016 in Dar es Salaam 
Incremental 
cost per 
MTCT 
averted for 
making at 
least 4 ANC 
visits 
Descriptive 
statistics and 
cost-
effectiveness 
analysis 
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4.2 STUDY SETTING  
All four studies were done within health care facilities providing PMTCT services in Dar es 
Salaam, Tanzania. Dar es Salaam is the largest commercial city and one of the 31 
administrative regions in the country. During the study period, the region consisted of three 
administrative districts named Kinondoni, Ilala and Temeke (Figure 4), although two new 
districts, Ubungo and Kigamboni, have been recently established making a total of five 
districts (119). As of the official census conducted (every 10 years) in 2012, there were 
4 364 541 people living in the Dar es Salaam region (16). Almost two thirds of Dar es Salaam 
residents live in informal, unplanned settlements with limited infrastructure (16).  
 
 
  
 
Figure 4. Map showing location of Tanzania and the three original districts of Dar es Salaam. 
Adapted from major cities of Tanzania. Retrieved from https://www.mapsofworld.com/tanzania/cities/ 
Copyright 2012-2013 by mapsofworld.com. & Administrative map http://cammi.de/images/ DaresSalaam-
cityadminmaps-small.jpg/ Copyright 2006 by Erika Cammi. 
 
Health care facilities in the country (120) are more concentrated in Dar es Salaam (8% of  
dispensaries, 7% of health centres and 15% of hospitals). Furthermore, doctor density is 
almost six times higher in the region than the national average, and there are almost 1.3 
nurses and 2.6 nurse midwives per 10 000 population, compared to the national average of 
2.6 medical doctors and 3.2 nurses and midwives combined per 10 000 population (87).  Dar 
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es Salaam has a total of 213 reproductive and child health facilities that provide PMTCT 
services. Of these, 185 facilities are supported by the Management and Development for 
Health (MDH), a PEPFAR-funded program, which provides technical support for HIV care 
and treatment in all public and some private facilities in Dar es Salaam (121). The health care 
facilities (private and public) in Tanzania offer services according to the national PMTCT 
guidelines (73) adapted from the WHO guidelines, which also describe important activities 
that should be carried out during each clinic visit.  
Studies I, II and III were done in the Ilala and Kinondoni districts in Dar es Salaam and study 
4 involved all three original Dar e Salaam districts (Figure 4). 
 
4.3 SAMPLING AND DATA COLLECTION (PAPERS I, II & III) 
4.3.1 Health care facility sampling 
The initial plan envisioned nesting the thesis studies within a large cluster-randomized trial, 
which aimed to evaluate the implementation of potential interventions for achieving 
universal access to PMTCT services to reduce transmission of HIV (122). During this time, 
option A was used as a standard of care for PMTCT in Tanzania. The trial used a two-by-
two factorial design where women were first randomly allocated to receive the CHW 
intervention or not, and then to receive either PMTCT Option B or A. The trial was planned 
to be conducted and had already started in public health facilities in two of the three Dar es 
Salaam districts, because another intervention supported by the UNICEF was taking place 
in Temeke district. However, following the rapid policy change mandating the country to 
implement Option B+ instead of option A, the trial was stopped prematurely. Thus the 
thesis studies were modified and conducted as stand-alone studies, which were conducted 
in the initially selected districts that together are home to 70% of Dar es Salaam residents 
(16). 
For Papers I, II and III, we conducted studies in health care facilities providing PMTCT 
services in Ilala and Kinondoni. In total, there were 150 ANC/PMTCT facilities in these 
two districts (49 in Ilala and 101 in Kinondoni), which included 92 non-public facilities 
(Figure 5).  Public health care facilities were used because they are more affordable to the 
majority of the population in need of basic health services and represent the real-life situation 
of health care facilities in Tanzania (83).  
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             Figure 5. Flow diagram of health care facility sampling, study 1, 2, 3 and 4 
 
4.3.2 Study participant sampling and recruitment 
Paper I: Based on the length of the questionnaire, we estimated that one interviewer could 
efficiently complete at least three interviews per day. Thus, at the health care facility level, 
each day the interviewers listed the names of the pregnant and breastfeeding women seeking 
PMTCT services. From the list, a simple random sampling was used to select three patients, 
then written consent was requested before inviting them to participate in an interview. The 
interviews were conducted when the women were exiting the clinics after receiving PMTCT 
services. If there were no patients registered for PMTCT services on a particular day, the 
interviewer returned to the health care facility at least twice before removing the facility 
from the list.   
Paper II:  All health care providers offering PMTCT services in the selected facilities were 
invited to participate in the study, 217 (87%) gave consent and were recruited. 
Paper III: We randomly sampled working days from the calendar on which to visit each of 
the selected facilities. On each of the sampled health care facility days, the observer visited 
the facilities and randomly selected nurse-patient interactions for the time and motion 
observation. 
150 facilities 
58 facilities 
Study 1 and 2 
36 facilities 
92 non-public 
health care 
facilities 
excluded 
22 facilities, 
enrolling <1 
patient /m 
excluded 
Access 
denied in 10 
facilities 
excluded 
    48 facilities 
Study 3 
26 facilities 
Study 4 
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4.3.3 Data collection Papers I, II and III 
Research assistants with a medical background were trained on the data collection tools. For 
Papers I, and II we used structured questionnaires conducted using the local language 
(Kiswahili). The survey questions were in a Likert scale form (123). These questions are 
appropriate for measuring a respondent’s opinion or attitude towards a given subject, thus 
capturing the intensity of the respondent’s feelings for a given item. The Likert scales allow 
respondents to indicate their degree of preferences or opinion including a neutral option 
without restricting them to a simple YES/NO answer.  
The research assistants administered the patient questionnaire (Paper I) face-to-face by and 
captured overall patient satisfaction, and satisfaction in relation to health system 
responsiveness (Appendix I). The provider questionnaire (Paper II) was a self-administered 
survey distributed by the research assistants and captured the health care provider satisfaction 
with the different aspects of the job and also turnover intentions (Appendix II). To ensure that 
patients interpreted the questions similarly (Paper I), important concepts such as the meaning 
of good communication, confidentiality and prompt attention were first defined in the 
questionnaire. A small compensation was given in Tanzanian shillings equivalent to US$ 3.1 
and US$ 5 to patients and health care providers respectively for the extra time spent in the 
clinic to complete the surveys.  
For Paper III, four trained research assistant with a medical background observed in real time 
the routine activities performed by the nurse and recorded the time spent on various PMTCT-
related activities. The time of each activity was measured in minutes using a stopwatch and 
then recorded on a time sheet prepared by the research team. To minimize a potential 
Hawthorne effect, health care providers were informed that the study aim was purely to 
estimate the time routinely spent on PMTCT activities for scientific purposes and not for 
work performance evaluation. 
 
4.4 SAMPLING AND DATA COLLECTION (PAPER IV) 
4.4.1 Patient outcomes 
The primary patient outcome used as a measure of effectiveness was MTCT within the first 
6-12 weeks of an infant’s life in relation to the number of ANC visits. We used the de-
identified patient level data extracted from the national care and treatment programme’s 
electronic database. The database collects information from all patients enrolled in care and 
treatment clinics (CTC) and is referred to as CTC2. The CTC2 database is used by more 
than 300 care and treatment clinics throughout the country to manage data on patients 
enrolled in CTCs. The database is based on the national HIV care and treatment monitoring 
and evaluation tools (124). The implementing partners, in collaboration with regional 
coordinators in each region, export the cleaned de-identified files from health care facility-
level electronic databases to the national database. MDH, as the implementing partner for the 
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Dar es Salaam region, provides technical support for this task and has permission to use the 
region’s de-identified data for evaluating the performance of the programme. We accessed 
the Dar es Salaam partially cleaned CTC-2 database through MDH containing the de-
identified routinely collected health system data in various datasets.  
We extracted, cleaned and linked the datasets relevant for this analysis including pregnancy, 
HIV-exposed infants (HEI), visits and medication datasets. We linked the mother datasets 
using the mother’s unique identification number (CTC-2 ID), and then we linked the infant’s 
dataset to the mother’s dataset using the unique infant identification number present in both 
databases. From the linked mother-infant database, we extracted information regarding the 
infant’s date of birth; date of the infant HIV test (DNA-PCR) the date of the HIV test results 
and the date of each clinic visit. We also extracted information related to the mother’s 
demographic characteristics, CD4 cell count, WHO disease stage, self-reported ART 
adherence (patients self-report they have been taking “all” ART tablets as prescribed in the 
previous visit) and infant feeding option choices.   
We identified a total of 4450 mothers who delivered between August 2014 and May 2016. As 
we were interested in studying the newly diagnosed pregnant women living with HIV, we 
excluded 2014 pregnant women already on ART. From the remaining 2436 newly diagnosed 
pregnant women living with HIV, a total of 100 mother-infant pairs with no information 
regarding the infant’s date of birth or the mother’s expected delivery date were excluded. 
Furthermore, an additional 27 mother-infant pairs were excluded because infants had a first 
DNA PCR test after 12 weeks post-delivery. The remaining sample of 2309 mother infant 
pairs was analyzed.  
4.4.2 Costing and unit costs 
We estimated costs from the service provider’s perspective using a micro-costing 
approach which involves the direct enumeration and costing out of inputs consumed in 
the treatment of a particular patient (125). The provider unit cost contribution for each 
integrated ANC/PMTCT service was calculated from the unit time and cost of a health 
care provider per patient visit observed in Paper III. The cost for tracking patients, who 
missed a clinic visit, was obtained from cost estimates documented in other empirical 
studies involving adults living with HIV in Dar es Salaam, Tanzania (126, 127).     
Medication costs included both the price of the antiretroviral medications and the cost of   
health care provider time spent in dispensing the ART. The price of ART were based on 
the market price as reported in the 2013 WHO Global Price Reporting Mechanism 
(GPRM)(128) and the 2016 Clinton Health Access Initiative (CHAI) reference price list 
(129). The actual cost of performing laboratory tests was obtained from another empirical 
study conducted in HIV clinics in Dar es Salaam (126). All costs and effects incorporated 
into the cost-effectiveness analysis occurred within the one-year time horizon, thus no 
discounting was done. 
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4.5 DATA ANALYSIS 
Statistical analyses for all four papers were performed using Stata software version 14 (Stata 
Corp 2014 Stata Statistical Software). 
4.5.1  Statistical analysis Paper I 
We first examined the distribution of the Likert scale patient responses using histograms and 
frequency tables, and then we dichotomized the variables for overall patient response and the 
patient-provider interaction to binary outcomes. The responses including “neutral”, “fair” and 
“poor” were labelled as “dissatisfied”, while “very good” and “good” were labelled as 
“satisfied”, the outcome of interest was being “dissatisfied” with the PMTCT services. We 
also dichotomized the responses for the independent variable; the responses including 
“neutral”, “fair”, and “poor were labelled as “poor”, whereas the responses including “very 
good” and “good” were labelled as “good”. The responses for the independent variables that 
were in a 3-item scale were categorized as “YES” if responses were “most of the time” or  
“sometimes”, and “NO” if the response was “no”. 
Using frequencies and Fisher’s exact test, we explored the association between the outcome 
“dissatisfaction with PMTCT services” and independent variables; both univariate and 
multivariate logistic regression analysis were used to investigate factors associated with 
patients being dissatisfied with PMTCT services. A stepwise logistic regression analysis was 
done, by including variables from the univariate analysis with p-value <0.2 in the model. 
Then we removed items with the highest p-value one at a time and re-fitted the model until all 
variables remaining in the final model had a p-value of <0.05. Taking into account the 
possible multiplicative interaction between the variables, we added their product terms in the 
model and a formal p-value for departure from interaction was obtained using a likelihood 
ratio test comparing the maximized log-likelihoods of the model with and without the product 
terms. In the final logistic regression model, we examined the variation of the probability of 
overall dissatisfaction with PMTCT services in relation to possible predictors and reported 
the results as odds ratios (ORs) and 95% confidence intervals (CI). The total visit time, the 
only continuous predictor that was significant, was modelled assuming linearity, and we used 
the restricted cubic splines with three knots (130) at fixed percentile of its distribution to 
examine potential departure from linearity. 
4.5.2 Statistical analysis Paper II 
For this Paper, we first assessed the internal consistency of the job satisfaction scale 
containing 42 questions with a 5-item Likert-scale organized in 9 domains related to various 
aspects of the health care provider’s job. These domains included remuneration, equipment 
and work context, workload, duties, harmony in the workplace, training, management, 
moral satisfaction and job stability (being able to keep the same job for a long time). The 
Cronbach alpha coefficients showed a fair reliability (0.69) for the job stability domain and 
good reliability (0.77 to 0.92) for the remaining 8 domains.       
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Similar to Paper I, we converted 5-item (job satisfaction) and 7-item Likert scale (turnover 
intention) responses to a binary outcome. For the 5-item Likert-scale, the responses including 
“neutral”, “dissatisfied” and “very dissatisfied”, were labelled as “dissatisfied” with current 
job, while the responses including “very satisfied” and “satisfied” were labelled as “satisfied” 
with current job.  For the 7-item Likert-scale, the responses including “very often”, “fairly 
often”, “often”, “occasionally”, “rarely” and “almost never” were interpreted as having an 
intention to leave, while those who reported “never” were considered to have no intention to 
leave their current job. 
For this Paper, the independent variables included in the model consisted of the 
characteristics of: the health care provider such as age, gender, education level, professional 
cadre and the time in current position; the nine domains summarizing various aspects of the 
provider’s job; and perceptions of the health care provider regarding Option B+ such as, if it 
will be the best option to implement, will it be preferred by women or will it be the best 
option for mothers and their babies. We summarized the data using proportions, and Fisher’s 
exact test was also used to test for association between the dependent variable (overall job 
satisfaction or turnover intentions) and the independent variables. 
To identify the predictors of overall job satisfaction among the various aspects of the health 
care provider’s job, separate multiple logistic regression models were created for each of the 
9 domains. Variables with the lowest p- values were selected from each model if the p-value 
was less than 0.2 and these were used to create new multiple logistic regression models. A 
backward elimination method was used to remove items with the highest p-value one at a 
time until the remaining items had a p-value <0.05. The model was adjusted for the health 
care provider’s opinions regarding the women’s preference for Option B+ because it had  a 
positive significant association with overall job satisfaction. The final model was further 
adjusted for age, education level, level of health care facility and professional cadre, as well 
as for clustering of standard errors at the health care facility level. Similar procedures were 
followed to identify the predictors of the turnover intention.  The interaction between 
significant predictors in the job satisfaction and turnover intention model was examined by 
adding their product terms in the respective final multiple logistic regression models and a 
formal p-value for departure from interaction was obtained using a likelihood ratio test 
comparing the Maximized log-likelihoods of the model with and without the product terms. 
The results are presented as Odds ratio (OR) and their 95% CI. 
4.5.3  Statistical analysis Paper III 
The characteristics of health care providers (nurses) were summarized as proportions and the 
time spent on each activity was summarized as mean and 95% CI. 
4.5.3.1 Identifying tasks that can be task-shifted 
Based on the WHO Global Recommendations, some of the PMTCT tasks such as HIV 
counselling and testing, HIV test interpretation, and patient follow-up and providing 
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adherence support can be performed by the CHW (109). Thus, we mapped the tasks 
recommended in the WHO task-shifting guideline against the tasks observed during the 
different types of PMTCT visits.  
4.5.3.2 Estimating the cost for activities as observed 
Estimation of the cost for the activities performed was based on the monthly government 
salary of nurses who are the main providers of the PMTCT service.   During the study period, 
a nurse officer earned a salary equivalent to US$ 495/month and enrolled nurses and nurse 
midwives earned a salary equivalent to US$ 438/month.  The weighted average salaries were 
calculated because different nurse cadres were observed to contribute different proportions of 
these visit times. The cost for each task was calculated by applying the unit cost to the time 
spent to complete a particular task during a specific visit 
4.5.3.3 Estimating the cost for activities as if they were task-shifted 
We calculated the total time of activities that could be task-shifted to CHWs and we applied 
various salary estimates for CHW. Since there was no established salary scale for this cadre 
in the country, we made assumptions for the level of the salary they could be paid. One 
assumption was based on the minimum salary (US$ 172 per month) for a formally trained 
Tanzanian health care provider equivalent to a CHW level in the public-sector health system 
(131). A second assumption was based on the remunerations (US$ 30 per month) paid to lay 
health workers in an empirical study in Tanzania (122, 127), and finally we used the upper 
bound of the remuneration range for CHWs in Tanzania (US$ 150), which was recommended 
in another study based on a normative analysis (132). The cost for each task that could be 
task-shifted was calculated by applying the unit cost to the time spent to complete a 
potentially task-shifted task during a specific visit. Here we assumed that a CHW would 
spend almost the same amount of time to complete a task-shifted task as the current health 
care provider. 
4.5.3.4 Estimating the potential cost savings 
The monthly salary estimates for nurses and CHW were converted to minute salary estimates, 
based on 22 working days per month and 8 working hours per day.  All costs were converted 
from Tanzanian shillings (TZS) to US dollars (US$), using the average exchange rate for the 
month of December 2015 (1 USD = 2154 TZS).  
To calculate the cost after task-shifting, we applied the per-minute cost estimate for CHW 
salary on a task that could be task-shifted and the weighted nurse’s salary to the activities that 
cannot be task-shifted. Finally, the potential cost savings due to shifting of tasks to CHWs 
was estimated as a difference between the cost before and cost after task-shifting.    
4.5.4 Statistical analysis Paper IV 
For this analysis, we first described baseline characteristics of the study patients in relation to 
the MTCT outcomes and the number of clinic visits attended (≥4 visits vs < 4 visits). The 
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resource used per patient, as estimated from the patient level data, was multiplied by the unit 
cost to obtain the cost per patient associated with PMTCT service utilization. The health 
outcome measure of effectiveness was the MTCT averted when women made at least 4 
ANC/PMTCT clinic visits.  
We used the Pearson chi-square test to test for difference in MTCT averted between pregnant 
women who made at least 4 clinic visits and those who made fewer than 4 clinic visits before 
delivery. The cost data were summarized in a Microsoft Excel 2010 spread sheet; this 
included the cost of the services utilized by the patient during their clinic visits, including cost 
for health care provider’s time, laboratory tests and ART.  
Cost-effectiveness was estimated as the incremental cost-effectiveness ratio (ICER) 
representing a gain in terms of the cost per MTCT case averted, defined as: 
 
ICER =                  (Cost ≥ 4 visits) - (Cost < 4 visits) 
(MTCT averted ≥ 4 visits) - (MTCT averted < 4 visits) 
To evaluate the effect of uncertainty related to the ART price estimates and cost of tracking 
PMTCT defaulters on ICER, we used a multi-way sensitivity analysis. To account for the 
uncertainty of these parameters, we changed simultaneously the value of each parameter over 
the upper and lower ranges of the reported estimates.  
   
4.6 METHODOLOGICAL CONSIDERATIONS 
Paper I and II used a structured questionnaire including Likert scale items. Thus it was an 
appropriate way to capture the opinions of patients regarding satisfaction with their care 
(Paper I) and of health care providers regarding satisfaction with their job and also with 
regard to intentions of leaving their job (Paper II). The problem with these types of questions 
is that respondents may avoid extreme responses for fear of negative implications. Research 
assistants with medical background were trained on the importance of confidentiality and 
anonymity and had no role in the care of the interviewed patients or supervision of the health 
care providers. However, there is still a potential risk that patients did not dare to be too 
negative about the studied PMTCT services (Paper I). This type of information bias is 
however highly unlikely for the data derived from the health care provider surveys (Paper II) 
which were self-administered and anonymous.  
Paper III, used a time and motion approach, a scientific method for recording time spent on a 
variety of tasks. The use of direct observation rather than self-reporting removed bias 
associated with over-reporting of the task times. The mapping of the task according to the 
WHO recommendation was useful for identifying which routine PMTCT tasks could be done 
by CHWs . Furthermore, the cost estimates were based on the plausible assumptions based on 
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the empirical evidence. A possible limitation is the assumption that CHWs would need the 
same amount of time as existing trained and experienced nurses to deliver a particular 
PMTCT service. This assumption is possibly biased because we did not observe the time 
taken by CHWs to complete tasks, however, with time and repetition of tasks, this can be 
achieved, as health cadres with comparatively short training have been observed as being 
very efficient at executing new complex tasks (133, 134). Neither did we estimate the cost 
of training the CHW to perform the tasks, which were to be delegated to them, thus our 
estimates of the cost saving could have been underestimated or overestimated.       
For Papers I, II and III, we used only public facilities and this may limit the generalizability 
of the findings to other non-public facilities in Dar es Salaam and the rest of the country. A 
patient or health care provider in non-public facilities could be more satisfied or dissatisfied 
as compared to those in public facilities. This is because, despite the high workload and low 
salaries, a health care provider prefers employment in public facilities because of the 
favourable pension scheme not offered in the private facilities (135). On the other hand, they 
may prefer a better working environment and remuneration benefits, which are limited in 
public health care facilities. However, despite the attractive remuneration, health care 
providers in the private health care facilities could be dissatisfied because of facing the 
pressure of increased accountability (136). Furthermore the time taken to complete the task 
could be different and because of relatively higher salaries, the unit cost may be higher than 
our estimates. Thus, since the public health care facilities represent a real life situation of a 
health care facility in Tanzania, where the majority can afford the health services and health 
care providers prefer the long-term benefits, our results are useful in this context. 
Paper IV is based on the economic evaluation comparing the number of ANC visits (<4 vs at 
least 4) in relation to MTCT.  One of the strengths of this study is that it provides empirical 
estimates from real-life data and there was no form of enhanced compliance with the visits.  
The MTCT outcomes were estimated from a large number of routine records of patients in 
the same region where the time motion study, which estimated the unit time for PMTCT 
tasks, used to estimate the health care provider’s time cost was done. Furthermore the patient 
population we used is representative of all women receiving PMTCT care at all levels of 
health care facilities in Dar es Salaam.   
Our analysis has several limitations; first the ICER is presented as a cost per unit MTCT 
averted. While this composite clinical end point is useful to estimate disease-specific cost, it 
is limited in terms of comparing the value for money of our estimates with other interventions 
and may be less useful to decision makers.    
Secondly, the analysis was restricted to the provider’s perspective and thus represents a 
conservative estimate because the total cost of ANC extends beyond health care costs 
including patient’s transport cost and time. The patient’s cost could have been significant, 
but was omitted because this data was not collected, since the provider perspective had 
been chosen for measuring cost. Finally, this study there is a likelihood of an 
underestimation of the true MTCT rate in mother-infant pairs with poor adherence to clinic 
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visits. This is because most women in this setting breastfeed their babies for at least 12 
months, and the ART adherence drops significantly with time post-delivery (137).  
 
4.7 ETHICAL CONSIDERATIONS 
The ethical permit for Papers I-IV was obtained from the Institutional Review Board (IRB) 
of the Muhimbili University of Health and Allied Sciences (MUHAS). Informed written 
consent was obtained from the women living with HIV (Paper I), health care providers 
(Paper II) and both (Paper III). In paper IV, we used the de-identified data routinely 
collected, stored in the national database and available for health service evaluations.  
Completed questionnaires were stored in a locked metal filling cabinet and a password-
protected electronic database only accessible to the research team. To maintain the patient 
confidentiality we did not use any patient identifying information such as names or clinic 
registration number. The women (Papers I, II and III) could have been exposed to the risk 
of being identified and stigmatized because of their HIV status. Thus, we trained the 
research assistants who because of their medical background were also keen to observe 
confidentiality. This was important because of patients’ fear of disclosure of their HIV 
status, for fear of subsequent HIV stigma and the risk of loss of economic support, factors 
that can affect the uptake and retention in PMTCT care (78).  
Health care providers could have been worried that the evaluation of their performance 
related to their responses or time spent on activities could be related to their remunerations 
or lead to them losing their job. Hence we made the questionnaires and the time motion 
datasheet anonymous by not including their names or any identifying information. We also 
explained clearly the purpose of the study and as such assured the health care providers that 
there was no relationship between our observations and surveys and the regular staff 
performance evaluations done by the Ministry of Health or local the government in these 
health care facilities.  
 
4.8 MY ROLE IN STUDIES INCLUDED IN THIS THESIS 
I was involved from the initial stages of designing the initially planned cluster randomized 
trial, where I helped design the training materials, train research assistants and supervise the 
trial. I then worked with my supervisors to redesign the new thesis studies and we drafted a 
modified analysis plan. I drafted the initial version of the surveys and requested permission to 
use and modify the tools developed by other researchers, such as the tool designed in Mali 
and Senegal and validated for use in African settings. I worked with my supervisors and other 
co-authors to finalize the surveys, which were used for data collection. I requested ethical 
clearance for all four papers. 
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I trained all research assistants and prepared them for data collection and supervised them 
during data collection, specifically for Paper I and II. I trained them on how to use the 
questionnaires and we piloted the questionnaires before creating a final version. For Paper III, 
I trained research assistants on time motion studies before starting data collection. I then 
mapped the observed tasks according to the WHO guidelines and calculated various estimates 
reported in the paper. For Paper IV, I requested permission to use the database and I cleaned 
and linked different datasets and created the final dataset used in the analysis.  Under 
supervision, I conducted all the data analysis for all four papers, drafted the manuscripts and 
finalized the papers after receiving feedback from co-authors and reviewers. 
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5 RESULTS AND DISCUSSION  
This PhD work is built on four studies that fill knowledge gaps and are important for 
addressing implementation challenges that limit the effectiveness of PMTCT interventions 
not only in Tanzania but also in similar settings. The main results will be presented and 
discussed under the subsections reflecting the title of each specific paper. 
 
5.1 PREDICTORS OF PATIENT DISSATISFACTION WITH SERVICES FOR 
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV (PAPER I) 
We recruited a total of 595 out of 600 eligible women living with HIV, who were receiving 
PMTCT services from 36 public health care facilities in Dar es Salaam and who had 
consented to an interview. The participants were generally happy with the services they 
received and only 8% (N=48) reported being dissatisfied with the care.  
5.1.1 Patient characteristics and overall satisfaction with PMTCT care   
The average age of the participants was 30 (±5.3) years. The majority (70%) had completed 
basic schooling (7 years) and nearly two thirds were in a formal relationship (married or 
cohabitating). Regarding HIV status, the majority of these women (81%) had known about 
their HIV status for at least one year and 86% had disclosed their HIV status to at least one 
family member. More than two thirds of the women received care in the dispensaries.    
Clinic opening hours were convenient to most of the women, and the services provided met 
the expectations of almost three quarters of them. However, none of these factors had a 
statistically significant influence on women’s dissatisfaction with PMTCT care. The women 
spent an average of two hours during their last visit to the ANC/PMTCT clinic, and those who 
reported a longer duration were more likely to report service dissatisfaction. 
5.1.2 Patient-provider interaction and patient satisfaction with PMTCT care   
The women living with HIV perceived the quality of provider-client interaction as high. This 
was reflected in their ratings of more than 90% in each of the following characteristics of the 
health care providers: communication, promptness of attention, confidentiality with patient 
information, understanding patients’ concerns and listening well to the patient. A slightly 
lower proportion (68%) of patients reported that nurses were good at giving an opportunity for 
patients to ask questions or giving clear explanations to patient’s queries (74%). These 
findings suggest that these important components of health system responsiveness (138, 139) 
were adequately fulfilled, and provide a plausible explanation for the observed low rates of 
dissatisfaction. As expected, a poor rating in any of these factors was significantly associated 
with dissatisfaction with the services.    
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5.1.3 Predictors of patient dissatisfaction with PMTCT care    
Patient dissatisfaction with PMTCT care was largely predicted by three main factors (Figure 
6), two of these are related to the quality of patient-provider interaction, and one is related to 
the time spent at the clinic. Patient dissatisfaction increased nearly six-fold if they felt that 
health care providers had a poor capacity to understand their concerns (OR 5.7, 95% CI 2.3–
14.0) and five-fold (OR 4.9, 95% CI 1.8–13.4) if patients perceived that the communication 
skills of the health care providers were of low quality. Patient dissatisfaction doubled if the 
women spent more than two hours of their time in the clinic (OR 2.3; 95% CI 1.1–4.7).  
 
 
Figure 6.  Predictors of patient dissatisfaction with PMTCT services 
 
The estimates show that every 30-minute increment in total visit time was associated with 
10% higher odds (95% CI 1.01-1.20) of being overall dissatisfied with PMTCT services 
(Figure 7). Considering all the factors together, the probability of being dissatisfied with 
PMTCT services was as low as 4% (95% CI 2% - 6%) when all the three factors were 
favourable and as high as 70% (95% CI 47% - 86%) when all factors were unfavourable. 
Long visit time and waiting time have been associated with reduced patient satisfaction and 
shown to affect the utilization of PMTCT services (79, 139, 140). 
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Figure 7. Odds ratio of dissatisfaction with PMTCT services according to time spent at the hospital 
(hours). Solid line is a linear trend, dashed lines are 95% confidence limits of the linear trend, and the long 
dashed line is the curvilinear trend estimated with restricted cubic splines. 
  
 
This study demonstrates that only a few women living with HIV reported dissatisfaction with 
the PMTCT care they had received. This is possibly because they also perceived the quality 
of the patient-provider interaction to be good or at least that the services they received met 
their minimum expectations. The positive influence of a good patient-provider interaction on 
patient satisfaction has been shown in another study involving people living with HIV (141). 
This finding has a major implication because patient satisfaction can influence the uptake of, 
retention in and adherence to ART services (79, 142, 143) and also serves as a determinant of 
adequate viral suppression (144).  
However, the high level of satisfaction we observed does not necessarily mean that the 
quality of services received by these women was optimal. The women may have feared to 
criticize the health care services because of the high respect they have for their health care 
providers and also out of fear of losing out on the future services they are entitled to (145). 
From our observation, it is evident that patient dissatisfaction can be more evident when the 
quality of patient-provider interaction is severely compromised, especially in the presence of 
unacceptably long visit time or if they are not treated with empathy. This highlights specific 
areas of care, which can be improved to meet the psychosocial and health needs of PMTCT 
clients.  
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5.1.4 Implications of the study findings 
Improving patient satisfaction has a positive effect on motivating the uptake of and 
adherence to the PMTCT care including lifelong ART to ensure better MTCT outcomes 
(104, 105, 144). Thus, our observation suggests that strengthening the service delivery 
component of the health care system, in the form of achieving high quality patient-provider 
interaction and short clinic visit time, can contribute to EMTCT. Furthermore, our findings 
point towards challenges related to the health workforce component, as health care providers 
may have difficulties in meeting the needs of their patients if their own needs are not met. 
Thus, the second paper in this thesis aimed to answer the question whether health care 
providers in these clinics were satisfied with their work. 
 
5.2 JOB SATISFACTION AND TURNOVER INTENTIONS AMONG HEALTH 
CARE STAFF PROVIDING SERVICES FOR THE PREVENTION OF 
MOTHER-TO-CHILD TRANSMISSION OF HIV (PAPER II) 
Among the 213 health care providers who completed the surveys, 54% were unhappy with 
their current job and slightly over a third of them were thinking of leaving. 
5.2.1 Baseline characteristics of health care providers in relation to their job 
satisfaction and turnover intentions 
Most of the health care providers (96%) were female, two thirds had a college education and 
over half were nurses, including 28% nurse officers and 32% nurse midwives. These health 
care providers were mostly working in primary health care facilities and they had spent a 
reasonable amount of time in their current job, only 6% had spent less than a year in it.  
5.2.2 Health care providers’ satisfaction with different aspects of their job   
The satisfaction of health care providers varied in different aspects of their job. While almost 
all reported to be dissatisfied with the remuneration and workload, they reported to be 
satisfied with the variety of duties, harmony in the workplace and moral aspects of the work 
(Figure 8). 
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Figure 8. Health care provider satisfaction in different domains involving their job: provider responses on 
a 5-item Likert scale on the questions “how satisfied are you with…” 
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5.2.3 Factors associated with satisfaction with the current job among 
PMTCT health care providers 
Health care providers who were not satisfied with their salaries were almost six times more 
likely to be dissatisfied with their current job (OR 5.6, 95% CI 1.2-26.8). This has also been 
reported in other resource-limited settings, where salaries are generally low (146). In high-
income countries, despite the high salaries, satisfaction is essential for influencing the 
intention of health care providers to stay in their workplace (147). Thus, the high 
dissatisfaction with salaries has a substantial effect on staff retention in settings where a 
critical shortage already exists.  
We also observed that the limited availability of protective materials such as gloves increased 
the likelihood of being dissatisfied with the current job four-fold (OR 4.0, 95% CI 1.5-10.6). 
This has also been observed elsewhere (148), and it is probably because it puts health care 
providers at risk of contracting infections, especially HIV (149). This underlines the 
importance of personal safety in the workplace, including adequate protection against 
infections and injuries.  
A poor job description and poor working hours also stood out as other important factors of 
job dissatisfaction among health care providers, resulting in a four-fold (OR 4.3, 95% CI 1.3-
14.7) and three-fold (OR 3.2, 95% CI 1.3-7.6) increase respectively in the odds of being 
dissatisfied with the current job.  It has been shown that, with a high workload and a high 
number of clients, the few available health care providers are often forced to assume 
additional responsibilities, with no choice for specific tasks (108, 149). Thus, their 
dissatisfaction may also be the result of a struggle to cope with competing demands of 
fulfilling both their professional (inadequate time to provide quality care) and personal 
(inadequate time to care for their families) requirements and expectations (149). Our 
findings also show that health care providers were happy to promote Option B+ and they 
had high hopes that their patients would feel the same way. This could possibly be the 
reason why, despite the low satisfaction of health care providers with their overall work 
situation, they were still able to convey hope to their patients, making them feel satisfied 
with the care they received. On the positive side, the dissatisfaction expressed by PMTCT 
providers was not inherent in any individual characteristics but largely due to health system 
issues that possibly could be modified. 
5.2.4 Factors associated with the intention of health care providers to leave 
the current job in PMTCT clinics 
Health care providers (the great majority being nurses and midwives) who were unhappy 
with their job stability were almost four times more likely to think about leaving their job 
(OR 3.7, 95% CI 1.3-10.5). This finding was unexpected since we interviewed health care 
providers from public health care facilities, where employment is permanent and entitles 
employees to a retirement pension. Similar thoughts of leaving one’s job were provoked by 
superiors who failed to recognize employees’ work performance (OR 3.6, 95% CI 1.7-7.6) or 
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kept them uninformed about institutional performance (aOR 2.7, 95% CI 1.3–5.8). Leaders 
that value and recognize staff contributions tend to promote retention in the workplace 
(150-152). Tanzanian health care managers could possibly benefit from more training in 
positive feedback and be made more aware of good leadership styles that promote job 
satisfaction and retention among public employees. 
5.2.5 Implications of the study findings 
The overall findings from this study have implications not only on the efficiency but also on 
the effectiveness and sustainability of the Tanzanian health care system. The country 
already struggles with a severe shortage of human resources for health (81, 88) and has a 
pool of health care providers that cannot be rapidly expanded (90). Therefore, both short 
and long-term alternatives to promote health care providers’ satisfaction and job retention 
are urgently needed to scale up and sustain high-quality PMTCT services in the country. A 
skilled and motivated health workforce is critical for achieving universal health coverage of 
health services, but workers continue to face increasing stress and insecurity (80). Thus, 
WHO suggests that in areas facing severe shortages of health care providers, innovations 
such as task-shifting can be used (109). Hence, in Paper III we evaluated the potential of 
task-shifting in improving efficiency in PMTCT service delivery. 
 
5.3 THE POTENTIAL OF TASK-SHIFTING IN SCALING UP SERVICES FOR 
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV: A TIME 
AND MOTION STUDY (PAPER III) 
For Paper III, we observed a total of 1 121 PMTCT-related tasks including 179 patient-
provider interactions, 57% from dispensaries and the remainder from health centres and 
hospitals.   
5.3.1  Observed time spent in various PMTCT activities 
Supporting earlier findings (79, 153), we also found that health care providers spend most of 
their time on activities involving communication and documentation. For example, during 
antenatal care, 44% of the 54 minutes spent on women’s first ANC visit (the entry point into 
the PMTCT cascade), was spent on HIV testing and counselling, while 22% of the time was 
devoted to various documentation. Similarly, half of the 15 minutes (95% CI 14–17 minutes) 
spent during the ANC follow-up visits was devoted to communication such as counselling a 
woman on safe infant feeding and checking their ART adherence. About 44% of the ANC 
follow-up visit time was spent on documentation and ART refill, while only 6% of the   time 
during this visit was spent on patient assessment.  
The first postnatal mother-baby PMTCT visit took about half an hour on average (95% CI 
26–32 minutes), with two thirds of the time being spent on infant HIV testing and counselling 
and documentation. Postnatal follow-up visits took about half as long as the first mother-
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infant visit, 13 minutes (95% CI 11–16 minutes) on average, but health care providers still 
managed to prioritize patient counselling over the time they spent on documentation. The 
initial patient-provider meeting and the quality of communication during the first ANC visit 
which includes counselling, have also previously been suggested to be an important aspect of 
fostering the continuity of PMTCT care (154).   Thus, relating to our earlier findings (Paper 
I), patients possibly had a reasonable time for quality communication with health care 
providers.   
5.3.2 Potential for saving nurses’ time by task-shifting some PMTCT 
activities to community health workers (CHWs) 
With the introduction of Option B+, the workload increased in ANC/PMTCT facilities for 
two reasons. This demanded more time from existing health care providers. First, there was a 
change in eligibility criteria that resulted in an increase in the number of pregnant women 
living with HIV initiating ART in ANC/PMTCT facilities (155). Secondly, ANC/PMTCT 
facilities were given additional responsibilities to offer full ART services including clinical 
and immunological disease monitoring until the HIV status of infant was confirmed (77). In 
Malawi, which was the first country to spearhead the scale up of Option B+, they found it 
necessary to use a task-shifting model to address the challenge of staff shortages (155).   
Realizing Tanzania’s challenges ahead, this study tried to find out how useful it would be to 
task-shift some of the nurses’ activities to CHWs. According to the WHO recommendations 
on task-shifting, CHWs could perform all tasks involving documentation and a large share of 
the communication tasks as well (109). Applying the WHO recommendations to our 
observation, we estimate that 94% of both the first and the follow-up visits at ANC could be 
task-shifted to CHWs. Similarly, 84% of the first postnatal PMTCT visit, and 100% of 
postnatal follow-up visits for PMTCT could be task-shifted from nurses to CHWs (Figure 9).  
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Figure 9: Task-shifting from nurses to community health workers  
CHW = community health worker, First ANC = first antenatal care PMTCT visit, ANC FU = antenatal care 
PMTCT follow up visit, first PNC = first postnatal care PMTCT visit, PNC FU = postnatal care follow up 
visit.     
  
 
 
5.3.3 Potential of saving per-patient cost by task-shifting some PMTCT 
activities to community health workers (CHWs) 
Task-shifting could also have cost implications. Assuming that all tasks were indeed task-
shifted according to the WHO recommendations, the average cost per visit could be 
substantially reduced. We estimated that the cost savings of task-shifting in PMTCT would 
be between US$ 1.3 and 2.0 for the first ANC/ PMTCT visit, US$ 0.4 and 0.6 for the 
ANC/PMTCT follow-up visit, US$ 0.7 and 1.0 for the first PNC/PMTCT visits respectively 
and US$ 0.4 and 0.5 for the PNC/PMTCT follow-up visit, based on our assumptions for 
CHW salary estimates (Table 4).    
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Table 4. Cost in US$ per PMTCT visit 
 
Visits Observa
tions 
Mean cost 
before task- 
shifting 
(1) 
Mean cost 
after task- 
shifting 
(2) 
 
Mean cost 
after task- 
shifting 
(3) 
 
Mean cost 
after task- 
shifting 
(4) 
First ANC visit 36 2.27 0.96 0.85 0.28 
ANC follow-up visit  69 0.65 0.27 0.24 0.08 
First PNC visit 40 1.28 0.60 0.55 0.27 
PNC follow-up visit 34 0.58 0.21 0.19 0.04 
 
 
ANC = antenatal care, PNC = postnatal care. 
(1): Calculated based on the weighted average salary of the publically employed nurse in Tanzania (nurse 
officer US$ 495, enrolled nurse and nurse midwife US$ 437). (2): Calculated based on the minimum wage for 
a formally trained health care provider in the public-sector health system in Tanzania (US$ 172 per month). 
(3): Calculated based on community health worker salaries proposed in a previous study for Tanzania (US$ 
150 per month). (4): Calculated based on remuneration paid to lay health workers in another study (US$ 30 
per month).   
 
One main barrier to task-shifting in PMTCT health care facilities in Tanzania is that the 
government has not employed CHWs yet and that it will take an initial investment to hire and 
train them before any cost savings could be realized. However, since it takes a shorter time 
and is less costly to train CHWs than nurses (156), it is plausible to assume that the  saving 
will still be large by using a task-shifting model.   
5.3.4 Implications of the study findings 
Implementing the task-shifting model has potential for increasing efficiency in delivering 
PMTCT care in Tanzania. Task-shifting can allow nurses to invest time on specialized tasks 
that require more skills (114), such as the assessment of pregnancy-related risks, HIV clinical 
disease staging and supervision of CHWs.  
The presence of CHWs in the clinic has been shown to reduce waiting time, improve patient 
flow, reduce the workload of health care providers (157) and improve adherence to ART 
(158). Thus, as we observed that a significant proportion of PMTCT tasks could be done by 
CHWs, task-shifting can enhance the scaling-up of PMTCT services in Tanzania and other 
similar settings, where the health care provider pool cannot be rapidly expanded (112). 
Linking to the previous two Papers (I and II), it is plausible to assume that task-shifting could 
reduce some of the challenges affecting the satisfaction of health care providers 
(unreasonable working hours) and patient satisfaction (long visit time). 
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5.4 HEALTH CARE COSTS ASSOCIATED WITH CLINIC VISITS FOR 
PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HIV (PAPER IV)   
We also conducted a secondary analysis on de-identified data from a cohort of 2 309 newly 
diagnosed pregnant women living with HIV to study MTCT outcomes. We thereafter applied 
the unit time and costs obtained from Paper III to estimate the health care cost and the cost-
effectiveness of optimal utilization of PMTCT clinics in relation to MTCT.  
5.4.1 Patient characteristics 
The medium age of the women in the cohort was 29.8 (±5.7) years and the medium 
gestational age (GA) was 22 (±7) weeks at the first clinic visit. The majority of the women 
were in the early WHO disease stage (89%) with an average CD4 cell count of ≥ 350 per µL 
(69%). About 72% of the women made their first ANC/PMTCT visit in their second 
pregnancy trimester and 95% reported good adherence to ART.    
5.4.2 Clinic visits and patient outcomes 
MTCT occurred in 2.8 mothers out of 100 during the first 12 weeks (N=65/2309; 95%CI; 
2.2%-3.6%). The rates were higher, 4.8% (95% CI; 3.6%-6.4), when women made fewer than 
4 ANC visits, but only 1.0 % (95% CI; 0.5%-1.7%) if they had attended ANC at least 4 
times. As the number of ANC and PMTCT visits increased, fewer events of HIV 
transmission occurred, and no transmission was observed when more than seven visits were 
made (Figure 10). 
 
Figure 10. Number of antenatal care visits before delivery in relation to mother-to-child transmission 
of HIV at 6-12 weeks of life 
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These findings indicate that adherence to a minimum of 4 ANC visits has the potential to 
reduce MTCT, thus fewer than 4 ANC visits by a pregnant woman living with HIV can be 
used as an important warning sign. Such women should be candidates for more intense 
counselling. We also observed that mothers who transmitted HIV to their infants had a lower 
CD4 cell count (330 vs 485 cells per µL; p=0.005), were more likely to be divorced or 
widowed (p=0.030), made their first ANC/PMTCT visit late (GA: 25.6 vs 21.9 weeks, 
p=0.001) and/or had initiated ART late (GA: 24.9 vs 22.3 weeks, p=0.030). Maternal 
immunosuppression is known to be an important risk factor for MTCT (159, 160).  Women 
who were widows or divorced were significantly more likely to make fewer than 4 ANC 
visits as compared to women in a formal relationship (76% vs. 24%; p=0.006). These women 
may have poor access to ANC because of limited financial or social support compared to 
women in a formal relationship (161). 
We also observed a significant association between making the first ANC/PMTCT visit late 
(27.8 vs 18.6 weeks, p<0.001) and the likelihood of making fewer than 4 visits compared to 
making at least 4 visits.  In addition to a late first visit, women who made fewer than 4 visits 
also missed an average of 2 visits before delivery. Similarly, compared to women who 
attended ANC/PMTCT clinic at least 4 times, women who made fewer visits were more 
likely to have initiated ART late (27.9 vs19.0 weeks, p=0.001). Furthermore, women who 
reported poor medication adherence (72.7% vs 27.3%, p=0.02) were more likely to have 
made fewer visits. Adherence to ANC visits has been shown to be related to both high 
adherence to ART, and retention in PMTCT care (162), the important factors associated with 
MTCT reduction. Thus, this can possibly explain our findings of less MTCT among women 
who made more visits. This is because during follow-up visits, clients are constantly 
reminded about the importance of adherence to ART and they would also get a refill of their 
ART supply. Other factors such as the mother’s age, infant feeding practices and health care 
facility level were not significantly related to MTCT outcomes or to the number of clinic 
visits.      
5.4.3 Cost and cost-effectiveness analysis 
Overall, a total cost of 160225 US$ was estimated to have been incurred for this cohort of 
2 309 women, as calculated from the cost for health care providers’ time spent on visits, 
laboratory tests and ART. The cost per patient was slightly higher for those who made at least 
4 visits compared to those who made fewer than 4 visits (102.1 vs 90.1). 
The incremental cost associated with making at least 4 clinic visits was 11100 US$, 
equivalent to an incremental cost-effectiveness ratio (ICER) of 336.4 US$ per MTCT case 
averted. The increased cost was a result of the additional service utilization related to more 
visits, which were missed by those who made fewer visits. For instance, those who made at 
least 4 visits received more ART prescriptions and had more interaction with health care 
providers. The estimates show that making at least 4 visits can potentially prevent more 
infections for an incremental cost of 336.4 US$ per infection averted. This may appear high 
but is associated with preventing more MTCT and possibly reducing future treatment costs 
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that will be incurred in case MTCT occurs. For instance, the lifetime cost for one HIV-
infected African child treated with a first-line ART regimen is estimated at $41 350 per child 
(163). Furthermore, based on the procurement prices of ART in low-and-middle income 
countries as reported by WHO in 2013, the cost per person year of treating an HIV-positive 
child ranges from 300 US$ for a child between 3 and 10 years and 438 US$ for a child less 
than 3 years of age (128). Thus, although we did not model our estimates for a lifetime 
horizon of an HIV-infected child, our estimates suggest that encouraging women to make 
frequent PMTCT visits can be a cost-effective intervention. This also remained true after 
varying multiple input for cost of health care providers’ time, laboratory test and medications 
within their lower and higher range values, the ICER was between 573.8 US$ and 971.8 US$   
(Table 5). 
Table 5: Costs and HIV infections averted for women under PMTCT Option B+ who 
made a minimum of 4 ANC visits compared to fewer than 4 visits in Dar es Salaam 
2014-2016.   
 
Unit cost 
US$ 
Fewer than 4 visits 
(MTCT=46/949) 
Minimum of 4 visits 
(MTCT=13/1275) 
Components of PMTCT services  
No of 
units 
Cost US$ 
No of 
units  
 Cost 
US$ 
First ANC/PMTCT visit  2.27 949 2154.2 1275 2894.3 
CD4 cell count tests  15.76 263 4144.9 504 7943.0 
PMTCT follow-up visits  0.65 949 1233.7 1275 4143.8 
Defaulter tracking  15 949 28470 0 0 
Antiretroviral medication  8 949 30368 1275 61200 
Hemoglobin test 0.85 144 122.4 226 192.1 
Serum creatinine test 0.37 33 12.21 62 22.9 
Alanine aminotransferase (ALT) test 0.88 37 32.56 78 68.64 
Maternal Cotrimoxazole 0.6 949 3416.4 1275 4590 
Total cost   69954.4  81054.7 
Incremental cost (US$) 11100.3     
ICER/MTCT averted (US$) 336.4     
 
5.4.4 Implications of the study findings 
Monitoring the number of ANC visits for pregnant women in PMTCT provides a simple tool 
to identify those most at risk of transmitting HIV to their infants. Thus, investing in earlier 
ANC visits (during the first trimester) and retention in PMTCT care for a pregnant woman 
living with HIV can prevent more infections and possibly reduce future treatment costs that 
will be incurred in case MTCT occurs. 
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6  CONCLUSIONS 
• Patients receiving PMTCT care in Dar es Salaam were generally happy with the 
services they received and were only dissatisfied with these services if they 
perceived that health care providers had poor communication skills, low capacity to 
understand patient concerns, or if the hospital visit time was too long.     
• More than half of health care providers in public health care facilities studied were 
dissatisfied with their current job, and turnover intentions were not unusual     
• Being dissatisfied with the job and having turnover intentions was influenced by 
multiple factors such as low salaries, unreasonably long working hours, unclear job 
descriptions, poor safety measures, poor job stability, and inadequate supervision 
and feedback. 
• Nurses working in PMTCT clinics spend a large proportion of their time on tasks 
that could be shifted to CHWs, which could also decrease the average cost per 
patient.  
• Most pregnant women living with HIV do not attend ANC clinic in the first trimester 
of their pregnancy, which could increase the MTCT risk as well as future treatment 
costs.  
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7 RECOMMENDATIONS  
  
• To address the existing PMTCT implementation and scale up challenges in 
Tanzania, the training and mentoring of health care providers and health managers 
as well as the service delivery models need to be improved to ensure: 
o Patient satisfaction and retention in care through a PMTCT delivery model 
that fosters good patient–provider interaction and cuts the waiting time at the 
clinic.  
o More attractive work environments through reasonable remuneration and 
working hours, clearer job descriptions, appropriate safety measures and job 
stability as well as better management performance. 
• Shifting tasks from nurses to CHWs should be explored at least as a short-term 
alternative to reduce nurses’ workload, health care costs and to improve efficiency 
in PMTCT service delivery.    
•   To reach the target of EMTCT of HIV and to reduce future spending on HIV care in 
resource-limited settings, more efforts must be invested into encouraging pregnant 
women to seek ANC services earlier, preferably during their first trimester, to adhere 
to their antenatal and postnatal visits, and also for mothers living with HIV to stay on 
ART for life. 
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